Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions-Reference-Cited by-同舟云学术

Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions

Published:2017-02-16 Issue:12 Volume:8 Page:20113-20121
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fioramonti Marco¹,Santini Daniele¹,Iuliani Michele¹,Ribelli Giulia¹,Manca Paolo¹,Papapietro Nicola²,Spiezia Filippo²,Vincenzi Bruno¹,Denaro Vincenzo²,Russo Antonio³,Tonini Giuseppe¹,Pantano Francesco¹

Affiliation:

1. Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy

2. Department of Orthopaedics and Trauma Surgery, University Campus Bio-Medico of Rome, Rome, Italy

3. Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progression in the Mechanism of Bone Metastasis and Bone-Targeted Drugs in Prostate Cancer;annals of urologic oncology;2024-02-24

2. Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma;Cancers;2023-01-15

3. Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison;Clinical Genitourinary Cancer;2022-06

4. Phase II Study of Cabozantinib in Patients With Bone Metastasis;The Oncologist;2022-05-07

5. Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment;International Journal of Molecular Sciences;2022-02-24